Blogs

Get up to date with what’s new from Suffolk Sexual Health Service, our partners and anything affecting sexual health in our county.

Sign up to our quarterly newsletter and have the latest updates delivered straight to your inbox – click here.

 

Contraception Spotlight of the Month: LARC

Hey everyone! Summer is here, and so is our contraception spotlight of the month: Long-Acting Reversible Contraception (LARC). LARC is a fantastic option for those looking for a reliable and

Contraception Spotlight: Condoms

Today, we’re talking about a topic that's crucial for keeping our sexual health game strong – condoms! Let’s break down everything you need to know about this trusty form of

Understanding Pornography: What You Need to Know

If you're reading this, you're probably curious about pornography—what it is, how it impacts us, and what you should be aware of. We're here to give you the lowdown in

Spotlight on STIs: Understanding Syphilis

At Suffolk Sexual Health Service, we continue our series on sexually transmitted infections (STIs) with a focus on syphilis this month. STIs are infections transmitted through unprotected sexual contact, including

Suffolk Sexual Health Service Launches with Provide Community at the Helm

In a notable milestone for community health services in Suffolk, the new Suffolk Sexual Health Service, commissioned by Suffolk County Council, launched last week, on Wednesday 1 May 2024. This

Clinic transitional opening times for Suffolk Sexual Health Service

As part of its commitment to providing accessible and comprehensive sexual health services, Suffolk Sexual Health Service (SSHS) has announced transitional opening times for its clinics across the region. These

 

 

Contraceptive Implant Protection Extended to 5 Years 

The College of Sexual and Reproductive Health (CoSRH) has announced the extension of use of the etonogestrel implant (Nexplanon®) to 5 years in the UK.

Available evidence supports use of the etonogestrel implant for up to 5 years, with maintained contraceptive effectiveness and no new safety concerns identified.